Vicapsys Life Sciences, Inc

Vicapsys, based in Athens, GA, is dedicated to developing innovative therapies targeting chronic diseases by focusing on localized modulation of immune and inflammatory responses. The company's core technology revolves around CXCL12, a pleiotropic cytokine, aimed specifically at curing Type 1 diabetes and managing related complications like diabetic foot ulcers and peritoneal adhesions.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesVicapsys Life Sciences, Inc

Partial Data by Infogroup (c) 2023. All rights reserved.